Literature DB >> 7595088

Developmental regulation of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (APOBEC-1) in human small intestine.

F Giannoni1, S C Chou, S F Skarosi, M S Verp, F J Field, R A Coleman, N O Davidson.   

Abstract

Apolipoprotein (apo) B mRNA editing is a site-specific cytidine deamination reaction responsible for the production of apoB-48 in mammalian small intestine. This process is mediated by an enzyme complex that includes the catalytic subunit, APOBEC-1. In the present study, it is shown that the developmental regulation of apoB mRNA editing in fetal human small intestine is closely mirrored by accumulation of APOBEC-1 mRNA. Similar results were obtained using Caco-2 cells, the data further suggesting that culture of these cells under conditions previously shown to promote differentiation produce an earlier and more marked induction of APOBEC-1 mRNA abundance. Complementary analysis of APOBEC-1 protein accumulation using immunocytochemical localization reveals its appearance to be temporally coordinated with the accumulation of APOBEC-1 mRNA and its distribution to be confined to villus-associated enterocytes. Previous studies demonstrated a close temporal association between the development of triglyceride synthesis and apoB mRNA editing in the rat liver and small intestine. Analysis of fatty acid CoA ligase, monoacylglycerol acyltransferase, and diacylglycerol acyltransferase activity in preparations of human liver and small intestine demonstrates activity of all three enzymes in the late first and early second trimester, suggesting that certain aspects of complex lipid biosynthesis in the human fetal small intestine and liver are regulated developmentally. The cues that modulate the post-transcriptional regulation of fetal human small intestinal apoB gene expression may thus include both temporal programming and events related to the emergence of lipid transport capability.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595088

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

1.  Polycomb repressive complex 2 impedes intestinal cell terminal differentiation.

Authors:  Yannick D Benoit; Manon B Lepage; Taoufik Khalfaoui; Eric Tremblay; Nuria Basora; Julie C Carrier; Lorraine J Gudas; Jean-François Beaulieu
Journal:  J Cell Sci       Date:  2012-03-30       Impact factor: 5.285

Review 2.  Gene regulation by mRNA editing.

Authors:  J Ashkenas
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

Review 3.  Role of the gut in lipid homeostasis.

Authors:  Nada A Abumrad; Nicholas O Davidson
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

4.  Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing.

Authors:  Z Chen; T L Eggerman; A P Patterson
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

Review 5.  Insights from human congenital disorders of intestinal lipid metabolism.

Authors:  Emile Levy
Journal:  J Lipid Res       Date:  2014-11-11       Impact factor: 5.922

6.  Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.

Authors:  M P Sowden; M J Eagleton; H C Smith
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

7.  The expression of apoB mRNA editing factors is not the sole determinant for the induction of editing in differentiating Caco-2 cells.

Authors:  Chad A Galloway; Harold C Smith
Journal:  Biochem Biophys Res Commun       Date:  2009-11-20       Impact factor: 3.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.